|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K2039/505 | (2013.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K2317/24 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K2317/31 | (2013.01) | ||
| C07K 16/30 | (2006.01) | ||
| C07K2317/41 | (2013.01) | ||
| C07K 16/32 | (2006.01) | ||
| C07K2317/522 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K2317/526 | (2013.01) | ||
| A61K 47/68 | (2017.01) | ||
| C07K2317/55 | (2013.01) | ||
| C07K2317/622 | (2013.01) | ||
| C07K2317/64 | (2013.01) | ||
| C07K2317/72 | (2013.01) | ||
| C07K2317/73 | (2013.01) | ||
| C07K2317/732 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| C07K2317/77 | (2013.01) | ||
| C07K2317/92 | (2013.01) | ||
| C07K2317/94 | (2013.01) | ||
| A61K 47/6855 | (2017.08) | ||
| A61K 47/6869 | (2017.08) | ||
| A61K 47/6879 | (2017.08) | ||
| C07K 16/32 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 47/68033 | (2023.08) |
| (11) | Number of the document | 3223848 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15862509.5 |
| Date of filing the European patent application | 2015-11-26 | |
| (97) | Date of publication of the European application | 2017-10-04 |
| (45) | Date of publication and mention of the grant of the patent | 2024-11-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CA2015/051238 |
| Date | 2015-11-26 |
| (87) | Number | WO 2016/082044 |
| Date | 2016-06-02 |
| (30) | Number | Date | Country code |
| PCT/CA2014/051140 | 2014-11-27 | WO | |
| 201562166844 P | 2015-05-27 | US |
| (72) |
WICKMAN, Grant Raymond , CA
NG, Gordon Yiu Kon , CA
WEISSER, Nina E. , CA
|
| (73) |
Zymeworks BC Inc. ,
Suite 800 - 114 East 4th Avenue, Vancouver, BC V5T 1G4,
CA
|
| (54) | METHODS OF USING BISPECIFIC ANTIGEN-BINDING CONSTRUCTS TARGETING HER2 |
| METHODS OF USING BISPECIFIC ANTIGEN-BINDING CONSTRUCTS TARGETING HER2 |